Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and menopausal women than in women of reproductive age. We investigated the associations among menopause, sustained virologic response (SVR), and liver damage in patients with CHC.METHODS:We performed a prospective study of 1000 consecutive, treatment-naïve patients 18 years of age and older with compensated liver disease from CHC. Liver biopsy samples were analyzed (for fibrosis, inflammation, and steatosis) before patients received standard antiviral therapy. From women (n = 442), we collected data on the presence, type, and timing of menopause; associated hormone and metabolic features; serum levels of interleukin-6; and hepatic tumor necrosis factor (TNF)-α.RESULTS:Postmenopausal women achieved SVRs less frequently than women of reproductive age (46.0% vs 67.5%; P < .0001) but as frequently as men (51.1%; P = .283). By multivariate regression analysis, independent significant predictors for women to not achieve an SVR were early menopause (odds ratio [OR], 8.055; 95% confidence interval [CI], 1.834-25.350), levels of γ-glutamyl transpeptidase (OR, 2.165; 95% CI, 1.364-3.436), infection with hepatitis C virus genotype 1 or 4 (OR, 3.861; 95% CI, 2.433-6.134), and cholesterol levels (OR, 0.985; 95% CI, 0.971-0.998). Early menopause was the only independent factor that predicted lack of an SVR among women with genotype 1 hepatitis C virus infection (OR, 3.933; 95% CI, 1.274-12.142). Baseline levels of liver inflammation, fibrosis, steatosis, serum interleukin-6 (P = .04), and hepatic TNF-α (P = .007) were significantly higher among postmenopausal women than women of reproductive age.CONCLUSIONS:Among women with CHC, early menopause was associated with a low likelihood of SVR, probably because of inflammatory factors that change at menopause

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C / VILLA, Erica; Karampatou, A; Cammà, C; Di Leo, A; LUONGO, Monica; Ferrari, A; Petta, S; Losi, L; Taliani, G; Trande, P; Lei, B; GRAZIOSI, Amalia; BERNABUCCI, Veronica; CRITELLI, Rosina Maria; Pazienza, P; Rendina, M; Antonelli, A; Francavilla, A.. - In: GASTROENTEROLOGY. - ISSN 0016-5085. - STAMPA. - 140:(2011), pp. 818-829. [10.1053/j.gastro.2010.12.027]

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.

VILLA, Erica;LUONGO, Monica;GRAZIOSI, Amalia;BERNABUCCI, Veronica;CRITELLI, Rosina Maria;
2011

Abstract

Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and menopausal women than in women of reproductive age. We investigated the associations among menopause, sustained virologic response (SVR), and liver damage in patients with CHC.METHODS:We performed a prospective study of 1000 consecutive, treatment-naïve patients 18 years of age and older with compensated liver disease from CHC. Liver biopsy samples were analyzed (for fibrosis, inflammation, and steatosis) before patients received standard antiviral therapy. From women (n = 442), we collected data on the presence, type, and timing of menopause; associated hormone and metabolic features; serum levels of interleukin-6; and hepatic tumor necrosis factor (TNF)-α.RESULTS:Postmenopausal women achieved SVRs less frequently than women of reproductive age (46.0% vs 67.5%; P < .0001) but as frequently as men (51.1%; P = .283). By multivariate regression analysis, independent significant predictors for women to not achieve an SVR were early menopause (odds ratio [OR], 8.055; 95% confidence interval [CI], 1.834-25.350), levels of γ-glutamyl transpeptidase (OR, 2.165; 95% CI, 1.364-3.436), infection with hepatitis C virus genotype 1 or 4 (OR, 3.861; 95% CI, 2.433-6.134), and cholesterol levels (OR, 0.985; 95% CI, 0.971-0.998). Early menopause was the only independent factor that predicted lack of an SVR among women with genotype 1 hepatitis C virus infection (OR, 3.933; 95% CI, 1.274-12.142). Baseline levels of liver inflammation, fibrosis, steatosis, serum interleukin-6 (P = .04), and hepatic TNF-α (P = .007) were significantly higher among postmenopausal women than women of reproductive age.CONCLUSIONS:Among women with CHC, early menopause was associated with a low likelihood of SVR, probably because of inflammatory factors that change at menopause
140
818
829
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C / VILLA, Erica; Karampatou, A; Cammà, C; Di Leo, A; LUONGO, Monica; Ferrari, A; Petta, S; Losi, L; Taliani, G; Trande, P; Lei, B; GRAZIOSI, Amalia; BERNABUCCI, Veronica; CRITELLI, Rosina Maria; Pazienza, P; Rendina, M; Antonelli, A; Francavilla, A.. - In: GASTROENTEROLOGY. - ISSN 0016-5085. - STAMPA. - 140:(2011), pp. 818-829. [10.1053/j.gastro.2010.12.027]
Villa, Erica; Karampatou, A; Cammà, C; Di Leo, A; Luongo, Monica; Ferrari, A; Petta, S; Losi, L; Taliani, G; Trande, P; Lei, B; Graziosi, Amalia; Bernabucci, Veronica; Critelli, Rosina Maria; Pazienza, P; Rendina, M; Antonelli, A; Francavilla, A.
File in questo prodotto:
File Dimensione Formato  
Gastro_2011.pdf

non disponibili

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 2.23 MB
Formato Adobe PDF
2.23 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/697484
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 95
  • ???jsp.display-item.citation.isi??? 86
social impact